August 24, 2020
“The ideal scenario would be for professional societies to recognize the long-term downstream benefits of PSA screening in terms of reducing the risk for prostate cancer metastases and death in men with more than a 10-year life expectancy,” said Dr. Jim Hu of Weill Cornell Urology. To learn more about prostate cancer screening guidelines, please click here
